Related Experiment Video
Updated: Jan 21, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Cognitive Impairment Is Independently Associated with Non-Adherence to Antithrombotic Therapy in Older Patients with
Hyun-Joo Seong1, Kyounghoon Lee2, Bo-Hwan Kim3
1Red Cross College of Nursing, Chung-Ang University, Seoul 06974, Korea.
Insights
Cognitive impairment, not health literacy, significantly increases stroke risk in older atrial fibrillation (AF) patients due to poor adherence to antithrombotic therapy. Healthcare providers must assess cognition and medication adherence in elderly AF patients.
Area of Science:
- Cardiology
- Geriatrics
- Neuroscience
Background:
- Atrial fibrillation (AF) patients require oral antithrombotic therapy to mitigate stroke risk.
- Cognitive impairment and low health literacy are prevalent in older AF patients, potentially leading to treatment non-adherence.
- Understanding factors influencing adherence is crucial for effective stroke prevention strategies.
Purpose of the Study:
- To investigate the impact of cognitive impairment and health literacy on non-adherence to antithrombotic therapy in older AF patients.
- To identify key risk factors for poor medication adherence in this vulnerable population.
Main Methods:
- Secondary analysis of baseline data from a 2018 cross-sectional survey of 277 older AF patients (≥65 years).
- Data collected via face-to-face interviews using self-reported questionnaires.
- Multiple logistic regression analysis was employed to assess the influence of cognitive impairment and health literacy on non-adherence.
Main Results:
- Over half (50.2%) of the studied AF patients were non-adherent to their antithrombotic therapy.
- Cognitive impairment was independently associated with a significantly increased risk of non-adherence (OR = 2.628, 95% CI = 1.424-4.848).
- Health literacy did not show a significant association with antithrombotic therapy non-adherence.
Conclusions:
- Cognitive impairment is a significant predictor of poor adherence to antithrombotic therapy in elderly patients with AF.
- Routine assessment of cognitive function and medication adherence is recommended for older AF patients.
- Further research is needed to explore factors contributing to cognitive decline and non-adherence in this demographic.
Abstract:
Atrial Fibrillation (AF) patients could reduce their risk of stroke by using oral antithrombotic therapy. However, many older people with AF experience cognitive impairment and have limited health literacy, which can lead to non-adherence to antithrombotic treatment. This study aimed to investigate the influence of cognitive impairment and health literacy on non-adherence to antithrombotic therapy. The study performed a secondary analysis of baseline data from a cross-sectional survey of AF patients' self-care behaviors at a tertiary university hospital in 2018. Data were collected from a total of 277 AF patients aged 65 years and older, through self-reported questionnaires administered by face-to-face interviews. Approximately 50.2% of patients were non-adherent to antithrombotic therapy. Multiple logistic regression analysis revealed that cognitive impairment independently increased the risk of non-adherence to antithrombotic therapy (odds ratio = 2.628, 95% confidence interval = 1.424-4.848) after adjustment for confounding factors. However, health literacy was not associated with non-adherence to antithrombotic therapy. Cognitive impairment is a significant risk factor for poor adherence to antithrombotic therapy. Thus, health professionals should periodically assess both cognitive function after AF diagnosis and adherence to medication in older patients. Further studies are needed to identify the factors that affect cognitive decline and non-adherence among AF patients.
Related Concept Videos
Cognitive Therapy
Beck's Cognitive Therapy
Arbitrary Inference
Arbitrary inference involves making conclusions without sufficient...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Cognitive Dissonance
Introduction to Test of Independence
The test statistic for a test of independence is similar to that of a goodness-of-fit test:

